Finance

Beta
Lists
300519:SHE
Zhejiang Xinguang Pharmaceutical Co Ltd
CNÂĄ13.12
-2.89%
(-0.39) 1D
Jun 8, 3:04:55 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300519...
Open
CNÂĄ13.03
High
CNÂĄ13.58
Low
CNÂĄ12.85
Mkt. cap
2.16B
Avg. vol.
2.84M
Volume
2.95M
Dividend
2.29%
Quarterly dividend
CNÂĄ0.08
Ex-dividend date
May 29, 2026
P/E ratio
37.46
52-wk high
CNÂĄ20.36
52-wk low
CNÂĄ12.85
EPS
CNÂĄ0.35
Shares outstanding
160.00M
No. of employees
309
Open
CNÂĄ13.03
High
CNÂĄ13.58
Low
CNÂĄ12.85
Mkt. cap
2.16B
Avg. vol.
2.84M
Volume
2.95M
Dividend
2.29%
Quarterly dividend
CNÂĄ0.08
Ex-dividend date
May 29, 2026
P/E ratio
37.46
52-wk high
CNÂĄ20.36
52-wk low
CNÂĄ12.85
EPS
CNÂĄ0.35
Shares outstanding
160.00M
No. of employees
309
News stories
From sources across the web
About Zhejiang Xinguang Pharmaceutical Co Ltd
CEO-
Employees309
FoundedNov 18, 1998
Headquarters-
SectorPharmaceutical industry
Websitexgpharma.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
47.69M
64.68M
59.74M
88.47M
Cost of goods sold
30.64M
35.60M
37.97M
48.33M
Cost of revenue
30.64M
35.60M
37.97M
48.33M
Research and development expenses
2.71M
3.06M
3.31M
2.83M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
9.77M
7.41M
10.76M
8.04M
Operating expense
13.66M
10.29M
16.44M
11.75M
Total operating expenses
44.29M
45.89M
54.41M
60.08M
Operating income
3.40M
18.79M
5.33M
28.39M
Other non operating income
-3.73K
-2.36K
-2.56K
-3.00K
EBT including unusual items
8.13M
17.29M
9.86M
30.47M
EBT excluding unusual items
7.16M
19.90M
8.11M
30.36M
Income tax expense
765.91K
3.86M
980.05K
4.10M
Effective tax rate
9.42%
22.32%
9.94%
13.46%
Other operating expenses
1.01M
-251.59K
2.61M
1.04M
Net income
7.37M
13.43M
8.88M
26.37M
Net profit margin
15.44%
20.76%
14.86%
29.80%
Earnings per share
-
-
-
-
Interest and investment income
3.77M
1.12M
2.79M
1.98M
Interest expense
-
-
-
-
Net interest expenses
3.77M
1.12M
2.79M
1.98M
Depreciation and amortization charges
-
-
-
-
EBITDA
7.20M
22.52M
9.01M
32.07M
Gain or loss from assets sale
3.72K
-3.72K
3.72K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer